$9.39 -0.24 (-2.49%)
11/27/2009 1:00 PM

Seattle Genetics, Inc. (SGEN)

CAPS Rating: 4 out of 5

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

Results 1 - 20 of 45 1 2 3 Next »

Recs

0
Member Avatar dcsccr (< 20) Submitted: 7/10/2009 11:53:34 AM : Outperform Start Price: $8.87 SGEN Score: -19.44

antibodies and their conjugates are the future of cancer therapeutics

Recs

0
Member Avatar gokylego (62.45) Submitted: 4/28/2009 11:01:51 PM : Outperform Start Price: $8.98 SGEN Score: -23.42

Partnered well with funding and a intriguing pipeline.

Recs

0
Member Avatar SpaceMonkey01 (83.47) Submitted: 3/29/2009 12:28:30 PM : Outperform Start Price: $9.61 SGEN Score: -41.14

Moving Average Convergence/Divergence (MACD) indicates a Bullish Trend.
Chart pattern indicates a Strong Upward Trend.
Relative Strength is Bullish.
Up/Down volume pattern indicates that the stock is under Accumulation.
The 50 day Moving Average is rising which is Bullish.
The 200 day Moving Average is rising which is Bullish.
Look for Support at 9.89
Watch for resistance at 10.84

Recs

0
Member Avatar Chooseandhold (36.18) Submitted: 11/8/2008 2:43:52 PM : Outperform Start Price: $10.89 SGEN Score: -31.90

Great biotech with a great pipeline and money

Recs

0
Member Avatar RNZ100 (80.96) Submitted: 10/8/2008 8:28:03 PM : Outperform Start Price: $8.79 SGEN Score: -6.02

Oversold (but then again, what isn't?!)

Recs

0
Member Avatar Jorgedig (38.77) Submitted: 6/4/2008 8:07:57 PM : Outperform Start Price: $8.54 SGEN Score: +28.06

I like the Hodgkins drug.

Recs

0
Member Avatar BostonBoulay (< 20) Submitted: 4/24/2008 11:45:39 AM : Outperform Start Price: $10.55 SGEN Score: +6.92

Great cancer research stock. Think in 2-4 years will be well past its recent 52 week high of 13.44

Recs

1
Member Avatar TMFBreakerBrian (99.33) Submitted: 3/31/2008 1:36:32 PM : Outperform Start Price: $9.03 SGEN Score: +18.27

Biopharmaceuticals are being valued at a premium and Seattle Genetics has the goods. Is it the blood cancer biologics version of solid tumor small molecule Exelixis?

Recs

0
Member Avatar WERDOSD44 (29.85) Submitted: 3/24/2008 4:59:38 PM : Outperform Start Price: $9.70 SGEN Score: +12.55

HAS INTRODUCED A CLENICAL TRIAL FOR SGN-33 TREATMENT OPTION FOR MDS

Recs

0
Member Avatar EzMoney1983 (< 20) Submitted: 3/20/2008 4:59:50 PM : Outperform Start Price: $9.00 SGEN Score: +19.10

Over the next 3 years look for Seattle Genetics to develop and more that triple in price with new forms of rev and more earnings than expected.

Recs

0
Member Avatar jtierney18 (< 20) Submitted: 3/18/2008 11:09:51 AM : Outperform Start Price: $8.06 SGEN Score: +29.57

it going up and we cant do nothing about

Recs

0
Member Avatar League28 (41.51) Submitted: 3/16/2008 10:47:57 AM : Outperform Start Price: $8.17 SGEN Score: +24.71

Biotech is the future and this group has some great innovations and brilliant management staff.

Recs

0
Member Avatar dhuck11 (< 20) Submitted: 3/14/2008 9:11:56 AM : Outperform Start Price: $8.50 SGEN Score: +24.47

Drugs, death, live forever, more drugs, bald men, angry women, everything is controled on drugs...you need a biotech company in your port...who knows what they will discover today...what cure is next and who is going to hit on it...there are many bald men out there waiting.

Recs

0
Member Avatar 94HUMMER (< 20) Submitted: 3/13/2008 11:16:42 PM : Outperform Start Price: $8.50 SGEN Score: +24.47

good internals, great partners, possible acquisition target

Recs

0
Member Avatar tagmusic (< 20) Submitted: 2/27/2008 9:25:52 PM : Outperform Start Price: $9.80 SGEN Score: +12.61

The Big C

Recs

1
Member Avatar Swarlington (< 20) Submitted: 2/26/2008 6:01:24 AM : Outperform Start Price: $9.57 SGEN Score: +14.62

Seattle Genetics is a solid Biotech company with outstanding potential. The insider buying has been great as they are very near Phase III trials. One year sales growth is 99.70% and Genetics is the future for medicine. Although Baby-Boomers are giving great potential to any drug company, as with all Biotech we still need a product to succeed.

Recs

0
Member Avatar Pheasanthill (57.49) Submitted: 2/20/2008 8:04:51 AM : Outperform Start Price: $9.72 SGEN Score: +11.38

great drug line,insider buying strong.they are nearing ph3 trials

Recs

0
Member Avatar PPT1 (93.82) Submitted: 2/13/2008 10:43:05 AM : Outperform Start Price: $9.45 SGEN Score: +15.03

Innovator of Monoclonal Antibody based drugs

Recs

0
Member Avatar valueoftiming (22.04) Submitted: 2/2/2008 5:12:52 AM : Outperform Start Price: $9.53 SGEN Score: +16.50

insiders

Recs

0
Member Avatar fooluser17 (90.24) Submitted: 1/10/2008 1:48:19 PM : Outperform Start Price: $11.77 SGEN Score: -1.46

It's a risk, but I'm thinking that genetics and their new drugs in trial will possibly pull through.

Results 1 - 20 of 45 1 2 3 Next »

Featured Broker Partners